Home / Inspections / 675098

FDA Inspection 675098 — Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company

Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company — FEI 2650089

The FDA completed an inspection of Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company on August 13, 2010 in Manati, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 13, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Manati, PR (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures

Facility

Other inspections at this facility

  • 1147009 (VAI Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1110480 (VAI Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1079769 (OAI Wed Feb 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1030016 (VAI Mon Sep 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 986929 (NAI Wed May 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources